Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Magnimer Compounds
AddedMar 20, 2024
UpdatedJun 18, 2026
Magnimer Compounds

Magnimer Compounds

Innovative chemical company creating sustainable biodegradable polymers to replace petroleum plastics.

Overview
Compare
Fundraising
Employees

Magnimer Compounds is an innovative chemical company focused on creating sustainable, biodegradable polymers to replace petroleum plastics. Their core product is a microbially-derived Polyhydroxyalkanoate (PHA) system, designed to provide a durable and eco-friendly alternative for consumer applications. The company aims to revolutionize the plastics market by offering a viable, environmentally-friendly solution.

Magnimer Compounds has made significant strides in developing and commercializing their PHA system, contributing to the reduction of plastic waste and environmental impact. Their efforts in sustainability have positioned them as a key player in the green chemistry sector, attracting attention from environmentally-conscious consumers and industries.

Magnimer Compounds - Similar Companies

Phaxtec logo

Phaxtec

phaxtec.com

Mango Materials logo

Mango Materials

mangomaterials.com

Danimer Scientific logo

Danimer Scientific

danimer.com

Radical Plastics logo

Radical Plastics

NatureWorks logo

NatureWorks

natureworksllc.com

Ourobio logo

Ourobio

ourobio.com

Microgreen Polymers logo

Microgreen Polymers

Integrity Bio-Chemicals logo

Integrity Bio-Chemicals

Magnomer logo

Magnomer

magnomer.com

Terramer logo

Terramer

terramerinc.com

Industrial Microbes logo

Industrial Microbes

imicrobes.com

Modular Genetics logo

Modular Genetics

BioLogiQ logo

BioLogiQ

biologiq.com

New Ortho Polymers logo

New Ortho Polymers

Pyran logo

Pyran

pyranco.com

Magnimer Compounds - Quick Facts

Who are Magnimer Compounds' competitors?

Companies similar to Magnimer Compounds include Phaxtec, Mango Materials, Danimer Scientific and Radical Plastics.

When was Magnimer Compounds' last funding round?

Magnimer Compounds' most recent funding round was for $120k (USD) in September 2020.

How much has Magnimer Compounds raised to-date?

As of Sep 8, 2020, Magnimer Compounds has raised a total of $120k (USD).

How many employees does Magnimer Compounds have?

Magnimer Compounds has 50 employees as of Feb 4, 2024.

Magnimer Compounds - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotechnology
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Bioplastics
  • Polymers
Tags
  • Biotech
  • Cleantech
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified